ADIPOQ and breast carcinoma: Given that decreased neovascularisation exerts antitumoural effects, the antiangiogenetic effect of this adipocytokine mediated by CASP1 upregulation might be another mechanism underlying the inverse association between adiponectin serum levels and breast cancer risk.